Literature DB >> 26270021

Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation.

Yoshihide Ueda1, Shinji Uemoto2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26270021     DOI： 10.1111/tri.12653

Source DB:  PubMed          Journal:  Transpl Int        ISSN： 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  3 in total

1.  Efficacy and safety of glecaprevir and pibrentasvir treatment for 8 or 12 weeks in patients with recurrent hepatitis C after liver transplantation: a Japanese multicenter experience.

Authors:  Yoshihide Ueda; Tsuyoshi Kobayashi; Toru Ikegami; Satoshi Miuma; Shugo Mizuno; Nobuhisa Akamatsu; Akinobu Takaki; Masatoshi Ishigami; Mitsuhisa Takatsuki; Yasuhiko Sugawara; Yoshihiko Maehara; Shinji Uemoto; Hiroshi Seno
Journal:  J Gastroenterol       Date:  2019-02-26       Impact factor: 7.527

2.  Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience.

Authors:  Yoshihide Ueda; Toru Ikegami; Nobuhisa Akamatsu; Akihiko Soyama; Masahiro Shinoda; Ryoichi Goto; Hideaki Okajima; Tomoharu Yoshizumi; Akinobu Taketomi; Yuko Kitagawa; Susumu Eguchi; Norihiro Kokudo; Shinji Uemoto; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2017-01-30       Impact factor: 7.527

3.  Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review.

Authors:  Camille Lenoir; Frédérique Rodieux; Jules A Desmeules; Victoria Rollason; Caroline F Samer
Journal:  Clin Pharmacokinet       Date:  2021-08-31       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.